TREA

79258264 - HUB

Follow

Information

  • Trademark
  • 79258264
  • Serial Number
    79258264
  • Registration Number
    6050134
  • Filing Date
    November 29, 2018
    6 years ago
  • Registration Date
    May 12, 2020
    4 years ago
  • Transaction Date
    January 10, 2025
    26 days ago
  • Status Date
    May 12, 2020
    4 years ago
  • Published for Opposition Date
    February 25, 2020
    4 years ago
  • Location Date
    May 12, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MOLINOFF, JEFFREY
  • Attorney Docket Number
    2078154-0002
    Law Office Assigned Location Code
    N40
  • Owners
Information
Mark Drawing Code
3
Mark Identification
HUB
Case File Statements
  • DM0000: The mark consist of the teal stylized wording "HUB" and a stylized outline design of cells in shades of teal. The white inside the cells is background only and is not claimed as a feature of the mark.
  • GS0051: Cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx
  • CC0000: The color(s) teal is/are claimed as a feature of the mark.
  • GS0011: Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes
  • GS0441: Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services
  • GS0421: Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine, drug and vaccine testing services, namely, testing of pharmaceuticals; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine
Case File Event Statements
  • 5/14/2019 - 5 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/9/2019 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 5/10/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/10/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/28/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/29/2019 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/10/2019 - 5 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/10/2019 - 5 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/28/2019 - 5 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/8/2019 - 5 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/8/2019 - 5 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/1/2019 - 5 years ago
    12 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 12/5/2019 - 5 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/5/2019 - 5 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/5/2019 - 5 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/17/2019 - 5 years ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/17/2019 - 5 years ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/19/2019 - 5 years ago
    21 - ASSIGNED TO LIE Type: ALIE
  • 12/17/2019 - 5 years ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/17/2019 - 5 years ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/17/2019 - 5 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/1/2020 - 5 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/1/2020 - 5 years ago
    23 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/1/2020 - 5 years ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/6/2020 - 5 years ago
    25 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 1/14/2020 - 5 years ago
    26 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 1/21/2020 - 5 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/17/2020 - 5 years ago
    27 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/22/2020 - 5 years ago
    29 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/22/2020 - 5 years ago
    30 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/22/2020 - 5 years ago
    31 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/22/2020 - 5 years ago
    33 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/22/2020 - 5 years ago
    32 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/5/2020 - 5 years ago
    36 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/5/2020 - 5 years ago
    34 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/5/2020 - 5 years ago
    35 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/25/2020 - 4 years ago
    39 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/12/2020 - 4 years ago
    40 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/22/2020 - 4 years ago
    37 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/25/2020 - 4 years ago
    38 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/3/2020 - 4 years ago
    44 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 8/12/2020 - 4 years ago
    41 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/15/2020 - 4 years ago
    42 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/15/2020 - 4 years ago
    43 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 4/5/2024 - 10 months ago
    45 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 5/7/2024 - 9 months ago
    46 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH